Latest Headlines

  1. New $500 Million Gene Therapy Drug Manufacturing Facility Announced By Pfizer (Sanford NC)
    8/21/2019

    Pfizer announced today an additional half billion dollar investment for the construction of its state-of-the-art gene therapy manufacturing facility in Sanford, North Carolina. This facility is anticipated to support Pfizer’s continuing investment in gene therapy research and development, similar to Pfizer’s Chapel Hill and Kit Creek, North Carolina research and development sites. This facility would expand the company’s presence in North Carolina, where there are currently more than 3,600 Pfizer colleagues, including 650 in

  2. New Auto-Injector Pen Assembly Capabilities Compliment Fill-Finish Capabilities In North America And Europe
    8/20/2019

    Thermo Fisher recently expanded their steriles capabilities to support clients requiring auto-injector devices for patient self-administration.  Located in dedicated and flexible GMP-compliant cabins, Thermo Fisher can accommodate both small and multi-million unit runs. This further increases company’s breadth of sterile services, which also includes cartridge and vial fill-finish, prefilled syringe assembly, primary and secondary packaging and label services. 

  3. Thermo Fisher Scientific Launches Operator Training Using Virtual Reality In Greenville, NC
    8/20/2019

    Thermo Fisher will dedicate its newly installed training center, designed with industry-leading resources and technologies. The facility is equipped with virtual reality and augmented reality capabilities, which will mimic a real-world operating environment and equipment, and reduce the amount of training time by 50%.

  4. Thermo Fisher Scientific Opens New Site In Buenos Aires, Argentina
    8/20/2019

    The purpose built, state-of-the art facility will help address the growing demand for development supply chain services and will focus on high quality secondary packaging solutions for customers and their patients. The new site will provide clinical trial support services including GMP storage, local labeling, secondary packaging, comparator sourcing, and handling and distribution of ambient and cold chain clinical trial supplies through to returns management.

  5. Thermo Fisher Scientific Opens New Laboratory To Support Sterile Drug Development
    8/20/2019

    Thermo Fisher Scientific expanded capacity at the North American site for sterile drug products in Greenville, NC and will now perform non-GMP work to support clinical phase programs.  The new development laboratory features two Lyostar3 freeze dryers with SMART technology that are capable of decreasing the number of runs required for lyophilization cycle development.

  6. CDMO Berkshire Sterile Manufacturing To Add Isolator, Autoclave And WFI Equipment
    8/15/2019

    Berkshire Sterile Manufacturing (BSM) announces its plan to add a third isolator line to expand capacity for future commercial clients. BSM is a state-of-the-art fill/finish contract manufacturer providing formulation and sterile filling services to companies producing injectable medications for pre-clinical through commercialization.

  7. SP Scientific Signs Partnership With Lab-i-DOSiTECNO Pharma Technologies To Offer Complete Aseptic Vial And Syringe Filling Lines
    8/15/2019

    SP Scientific announces the signing of a new partnership agreement with Lab-i-DOSiTECNO Pharma Technologies (Barcelona, Spain) enabling both companies to offer complete aseptic vial and syringe fill-finish lines lines for Injectable, Ophthalmic & Oral Products in Liquid and Powder Form.

  8. Nephron & Clemson University Partner On A Robotic Syringe Filling Automation Technologies
    8/12/2019

    Nephron Pharmaceuticals Corporation is partnering with Clemson University to create a robotic solution for syringe-filling automation to enhance sterile manufacturing in the pharmaceutical production process and keep up with growing hospital demands.

  9. Facility Design Takeaways From Novartis And University Of Pennsylvania Cell Therapy Facility
    8/9/2019

    In August the Novartis Institutes for Bio-Medical Research, based in Cambridge, Massachusetts, and the University of Pennsylvania’s Perelman School of Medicine (Penn Medicine) announced they had entered into an exclusive global research and licensing agreement. Under the alliance, Penn Medicine granted Novartis an exclusive worldwide license to the technologies used in an ongoing trial of patients with chronic lymphocytic leukemia (CLL) as well as future therapies based on chimeric antigen receptor (CAR) technology developed through the collaboration.

  10. Bayer Increases Cell Therapy Presence With Acquisition Of BlueRock Therapeutics
    8/8/2019

    Bayer AG and BlueRock Therapeutics recently announced an agreement under which Bayer will fully acquire BlueRock Therapeutics, a privately held US-headquartered biotechnology company focused on developing engineered cell therapies in the fields of neurology, cardiology and immunology, using a proprietary induced pluripotent stem cell (iPSC) platform.